Navigation Links
BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences

available typical and atypical antipsychotic drugs while achieving a much higher safety profile as evidenced by a lack of metabolic or extrapyramidal side effects.

BL-1020 is being developed by BioLineRx, Ltd. under a worldwide exclusive license from Ramot at Tel Aviv University Ltd. and Bar-Ilan Research and Development Company Ltd., the technology transfer arms of Tel Aviv University and Bar-Ilan University respectively. BL-1020 was discovered by Professor Abraham Nudelman from the Department of Chemistry, Bar-Ilan University; and Ada Rephaeli, Ph.D., Professor Abraham Weizman, MD, and Irit Gil-Ad, Ph.D. from the Sackler Faculty of Medicine, Tel Aviv University.

About BioLineRx

BioLineRx, a clinical stage drug development company traded on the Tel Aviv Stock Exchange (TASE: BLRX), is dedicated to building a robust pipeline of promising therapeutics for unmet medical needs. The Company's leading programs are for schizophrenia and treatment of damaged heart tissue post-myocardial infarction. Additional products under development include compounds for the treatment of cancer and CNS, cardiovascular, metabolic, infectious and autoimmune diseases.

BioLineRx advances projects from early stage discovery and lead generation to advanced clinical trials, regulatory approval and marketing. Partnering with researchers, universities and biotech companies to further the commercialization of promising compounds, BioLineRx seeks to enrich the pipeline of large pharmaceutical companies seeking their next blockbuster drugs. The Company was founded in 2003 by leaders in the Israeli life science arena including Teva Pharmaceuticals Ltd, Giza, Pitango, Hadasit and the Jerusalem Development Authority. For more information, please visit www.biolinerx.com.

This press release contains "forward-looking statements." These statements include words like "may," "expects," "believes," "scheduled" and "intends," and describe opinions about future events. These
'"/>




Page: 1 2 3

Related medicine technology :

1. BioLineRx Presents Data From Successful Phase I Trial for BL-1020 in Schizophrenia at American Psychiatric Association Conference
2. BioLineRx Presents Data on BL-1040 at Cardiovascular Revascularization Therapies Conference Demonstrating Potential to Reduce Deterioration of Infarcted Heart Tissue and Maintain Functionality
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
Post Your Comments:
(Date:9/3/2015)... UNION CITY, Calif. , Sept. 3, 2015 /PRNewswire/ ... company manufacturing point-of-care blood instrumentation and consumables to the ... Ross Taylor , chief financial officer, will present at ... Conference 2015 on Thursday, September 10, 2015 at 11:00 ... Omni Berkshire Place Hotel in New York ...
(Date:9/3/2015)... 03, 2015 Research and ... the "Diabetes Care Devices Market In Brazil, Russia, ... Meters, Continuous Glucose Monitors, Testing Strips, Lancets, Insulin Pumps, ... report to their offering. The BRIC diabetes ... USD 1.7 Billion in 2015 and is poised to ...
(Date:9/3/2015)... 3, 2015  Four financial reasons to reduce ... paper released by Leaf Healthcare, Inc . ... & Quality (AHRQ), pressure ulcers cost the ... . In addition to direct treatment related costs, ... and negatively impact hospital performance metrics. On top ...
Breaking Medicine Technology:The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020 2The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020 3Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 2Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 3
... Partners, a leading New York-based private equity firm ... and financial services companies, announced today the acquisition ... of information-based services which play an integral role ... and medical devices. WIRB is the ...
... DUBLIN, Ohio, Feb. 29, 2012 Earlier today the federal ... the DEA,s immediate suspension of our license to ship controlled ... this decision and have noticed our appeal of this decision ... Our contingency plans will be immediately activated, ...
Cached Medicine Technology:Arsenal Capital Partners Announces the Acquisition of Western Institutional Review Board 2
(Date:9/3/2015)... ... September 03, 2015 , ... The Linda Hall Library ... of a comet, the IceCube observatory at the South Pole, and the interior of ... Fall Lecture Series for the world's foremost independently funded research library devoted to science, ...
(Date:9/3/2015)... ... September 03, 2015 , ... B. ... has been retained to lead a national chief executive officer recruitment ... firms in the healthcare industry, B. E. Smith has recently placed more than ...
(Date:9/3/2015)... Montreal, CANADA (PRWEB) , ... September 03, 2015 , ... ... technologies, today announced that it will be spotlighting its award-winning print and artwork inspection ... Global Vision team September 16 and 17 at the Olympia London, booth #F33 , ...
(Date:9/3/2015)... ... September 03, 2015 , ... DiabetesSisters Welcomes ... to announce the additional of Carol Wysham, MD, to their esteemed Board of ... Karczmarczyk, Donna Rice, David Warren, Matt Stella, Tricia Cedotal, Andrea Thomas, Wanda Nicholson ...
(Date:9/3/2015)... ... ... ProScrub is a set of automated tools that allow Final Cut Pro ... without the use of keyframes. Utilize ProScrub's powerful sliders to determine the number ... to energetic video productions. ProScrub is a Final Cut Pro X ...
Breaking Medicine News(10 mins):Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 2Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 4Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 5Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2
... the Ramazzini Institute for cancer research in Italy say their ... laboratory animals "at doses very close to the acceptable daily ... that while rats fed aspartame ate less food, there was ... The study was performed in 1,800 rats during their full ...
... hay fever or any of the allergic conditions can reduce ... be fatal. ,Variations in certain genes in adults can ... asthma and other allergic reactions. And these gene variations also ... cancer in the same adults. The researchers of Ohio State ...
... has recently approved human volunteer trials for the country's second ... A vaccine for the developing world, where anti-retroviral drugs are ... the ultimate prize in the fight against AIDS. But efforts ... to mutate. ,After South Africa , India has ...
... Ongole town in Andhra Pradesh has started using its public ... departures of trains but also messages about how to prevent ... India has high incidence of prostitution and AIDS. ,Says ... HIV/AIDS like mad. I witness a lot of homosexual activity ...
... lived longer than patients// given a placebo. ,Lung cancer ... women. Two studies were conducted by Canadian –led international research ... first study was conducted by Dr. Timothy Winton of the ... study was done to prove that if chemotherapy is given ...
... or panoramic radiographs can be effective in detecting blocked// ... a stroke. ,Researchers from Virginia Commonwealth University School ... find out about the oral health of the patient ... blocked carotid artery in the patient. ,The ...
Cached Medicine News:Health News:Can Ajinomoto cause cancer? 2Health News:The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines 2Health News:Drug Tarceva for End-stage Lung cancer 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: